Navigation Links
St. John Hospital 1st in Region to Offer Innovative Chemotherapy Delivery System
Date:11/4/2011

DETROIT, Nov. 4, 2011,  /PRNewswire-USNewswire/ -- A unique treatment involving the use of hot chemotherapy is being offered at St. John Hospital and Medical Center. SJH&MC is the first hospital in Southeast Michigan and one of only approximately 20 centers nationwide to offer the treatment.

Know as Hyperthermic Intraperitoneal Chemotherapy, or HIPEC, the procedure has applications for a number of advanced cancers that have spread to the lining of the abdominal cavity, including colorectal, gastric, ovarian, appendiceal, and mesothelioma. For these patients, chemotherapy through a vein can only give them an additional few months to live.

The treatment involves surgically removing cancerous tumors from the abdominal cavity, then bathing the cavity with hot chemotherapy. The surgeon continuously circulates a heated, sterile chemotherapy solution throughout the abdominal cavity for up to two hours, killing remaining cancer cells without damaging normal cells in the body. The solution is then removed and the incision is closed.

Delivering the heated chemotherapy throughout the abdominal cavity distributes the drug thoroughly and allows it to directly penetrate the areas of cancer and reach areas where cancer cells aren't easily visible. Because the chemotherapy is delivered directly to the tumor, many of the side effects associated with intravenous administration of these powerful drugs can be avoided.

"This procedure has been proven to extend the lives of patient's and improve their quality of life," says Richard Berri, M.D., director of surgical oncology at St. John Hospital and one of only surgeons in the world trained to perform the operation. For many patients with advanced cancers that have spread to the abdominal cavity this is their only viable treatment option. Unlike other cancer treatments that only treat the symptoms of abdominal cancers; HIPEC can actually stop the growth of abdominal cancers."

St. John Hospital and Medical Center's Surgical Oncology Program, led by Dr. Berri, provides the most comprehensive and current surgical evaluation and treatment to patients with malignancies that can be treated surgically, including pancreas, liver, colorectal and stomach cancer. SJH&MC also offers the only Peritoneal Malignancies Program in Michigan to offer HIPEC.


'/>"/>
SOURCE St. John Providence Health System
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. MedImmunes Motavizumab Reduced RSV Hospitalizations by 83 Percent Among High-Risk Native American, Full-Term Infants in Placebo-Controlled Phase 3 study
2. Gilbert Hospital Continues Cutting Edge Treatments
3. Siemens Preclinical Imaging System Helps The Methodist Hospital in Houston Further Its Research Mission
4. New Data Show Doripenem as Effective as Commonly Used Therapies in Treating Hospital-Acquired Pneumonias
5. AspenBio Pharma Reports Strong Results with Appendicitis Triage Blood Test from Large Multiple Hospital Study
6. INVEGA(TM) Significantly Reduced Symptoms of Schizophrenia Compared to SEROQUEL(R) in Acutely Ill, Hospitalized Patients
7. Cardinal Health Releases New Tool to Combat MRSA Infections in Hospitals
8. Hospital to Hold MRSA Briefing for Media and Community Leaders
9. Arizona Heart Hospital Reaches Settlement Regarding Clinical Research Matter
10. Providence Hospital Study Finds Communication System Leads to Faster Heart Attack Treatment
11. Allegheny General Hospital Performs First Liver Transplant
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2017)... 18 months after its February 2016 launch, market access ... of three new senior people to its rapidly expanding ... and James Wright bring decades of specialist ... Tammy Wynne joins as Director, Value Communication, ... over ten years, experience in global market access consultancy ...
(Date:9/1/2017)...  Bayer will present the latest research from across its ... (ESMO) 2017 Congress, September 8-12 in Madrid, Spain ... clinical data on Bayer,s marketed portfolio and late-stage compounds as ... "We value the opportunity to ... at ESMO," said Carsten Brunn , Head of Pharmaceuticals, ...
(Date:8/28/2017)... Hill-Rom Holdings, Inc. (NYSE: HRC), will present at ... 2017, in New York . John ... to present at 11:05 a.m. Eastern Time. ... . A recorded replay will be available one hour after ... About Hill-Rom Holdings, ...
Breaking Medicine Technology:
(Date:9/19/2017)... ... September 19, 2017 , ... With ... community have raised more than $15,000 in just a couple of weeks for ... grappling matches and world-class instructor seminars, organizers expect to double those initial funds ...
(Date:9/19/2017)... ... September 19, 2017 , ... Only a few physicians were selected to receive ... Ross A. Clevens, MD, FACS . The founder and medical director of Clevens ... who trained at Yale, Harvard and the University of Michigan. He has served patients ...
(Date:9/19/2017)... York, NY (PRWEB) , ... September 19, 2017 ... ... firm, announced today the addition of strategic marketing leader, Denise Flannery, to its ... Strategic Marketing, Brand and Management Consultant, Denise will work with clients across different ...
(Date:9/19/2017)... ... 19, 2017 , ... PAPA Healthcare, Inc. announced today, the ... Healthcare helps fill gaps, provide essential insights, and improve productivity.” The story ... leveraging PAPA Healthcare’s post-acute productivity and analytics solutions. , St. Vincent’s Home Infusion ...
(Date:9/19/2017)... Dallas, TX (PRWEB) , ... September 19, 2017 , ... ... has settled over 175,000 debt accounts, translating to in excess of $835 million in ... card debt and other unsecured loans are some of the categories of debt settled ...
Breaking Medicine News(10 mins):